Anti-Hypertensive Drugs - Lesotho

Lesotho

in Lesotho, a country in southern Africa, is projected to experience a significant increase in revenue within the Anti-Hypertensive Drugs market.
In 2024, the projected revenue is expected to reach US$0.42m.
This growth is anticipated to continue with an annual growth rate (CAGR 2024-2029) of 0.00%.
By 2029, the market volume is estimated to reach US$0.42m.
When compared globally, it is important to note that United States is expected to generate the highest revenue within the Anti-Hypertensive Drugs market.
In 2024, the projected revenue for the United States is an impressive US$12,290.00m.
Lesotho's market for anti-hypertensive drugs is experiencing a surge in demand due to the rising prevalence of hypertension in the country.

Key regions: Japan, India, Italy, Brazil, South Korea

Market

Region

Region comparison

Currency

Analyst Opinion

Lesotho, a landlocked country in southern Africa, has a growing demand for healthcare services due to its increasing population and rising incidence of non-communicable diseases. Among these diseases, hypertension has become a major health concern in the country, leading to the growth of the Anti-Hypertensive Drugs market.

Customer preferences: Lesotho has a predominantly rural population, which poses challenges in terms of accessibility and availability of healthcare services. However, with the increasing awareness about hypertension and its complications, more people are seeking medical attention and are willing to spend on medications. As a result, there is a growing demand for affordable and effective anti-hypertensive drugs in the country.

Trends in the market: The Anti-Hypertensive Drugs market in Lesotho is primarily driven by the increasing incidence of hypertension, which is attributed to changing lifestyles, urbanization, and aging population. The market is dominated by generic drugs due to their affordability and availability. However, there is a growing trend of prescription of branded drugs by healthcare practitioners, which is expected to drive the growth of the market. Additionally, there is a rising demand for combination therapies, which offer better efficacy and convenience to patients.

Local special circumstances: Lesotho faces several challenges in terms of its healthcare system, including inadequate infrastructure, shortage of healthcare professionals, and limited access to essential medicines. However, the government has taken several initiatives to improve the healthcare system, including the provision of free primary healthcare services and the establishment of a national health insurance scheme. These initiatives are expected to increase the accessibility of healthcare services and drive the growth of the Anti-Hypertensive Drugs market in the country.

Underlying macroeconomic factors: Lesotho's economy is heavily dependent on agriculture, mining, and textile industries, which have been adversely affected by the COVID-19 pandemic. The pandemic has also led to disruptions in the supply chain of pharmaceutical products, leading to shortages and price fluctuations. However, the government has taken measures to mitigate the impact of the pandemic on the healthcare system, including the provision of essential medicines and medical supplies. The Anti-Hypertensive Drugs market in Lesotho is expected to recover gradually as the country's economy stabilizes and the healthcare system improves.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.